Compound information
- Natural Products
- NACP161378
- Molecular Formula
- C29H40N6O6
- Molecular Weight
- 568.300933 g/mol
- Structure
-
- IUPAC Name
- 2-[[2-[[2-(benzyloxycarbonylamino)-3-phenyl-propanoyl]amino]-4-methyl-pentanoyl]amino]-5-guanidino-pentanoic acid
- InChI
- InChI=1S/C29H40N6O6/c1-19(2)16-23(25(36)33-22(27(38)39)14-9-15-32-28(30)31)34-26(37)24(17-20-10-5-3-6-11-20)35-29(40)41-18-21-12-7-4-8-13-21/h3-8,10-13,19,22-24H,9,14-18H2,1-2H3,(H,33,36)(H,34,37)(H,35,40)(H,38,39)(H4,30,31,32)
- InChI Key
- YIYMRLVKQIKDBH-UHFFFAOYSA-N
- SMILES
- O=C(OCC=1C=CC=CC1)NC(C(=O)NC(C(=O)NC(C(=O)O)CCCNC(=N)N)CC(C)C)CC=2C=CC=CC2
- CAS
- SuperClass
- Organic acids and derivatives
- Class
- Carboxylic acids and derivatives
- SubClass
- Amino acids, peptides, and analogues
- Source
- CNP0023108
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 41 | Ring Count | 2 |
Heteroatom Count | 12 | Rotatable Bond Count | 16 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 7 |
Topological Polar Surface Area | 195.73 Å2 | LogP | 1.614 |
LogS | -2.69 | LogD | 1.201 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.011 | Pgp substrate | 0.99 |
HIA | 0.0 | F20 % | 0.48 |
F30 % | 0.0 | Caco-2 | -6.699 |
MDCK | -5.821 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.67 | PPB | 87.851 |
VD | 0.46 | Fu | 0.788 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.001 | CYP1A2 substrate | 0.5 |
CYP2A6 substrate | 0.292 | CYP2B6 substrate | 0.344 |
CYP2C19 inhibitor | 0.038 | CYP2C19 substrate | 0.227 |
CYP2C8 substrate | 0.452 | CYP2C9 inhibitor | 0.143 |
CYP2C9 substrate | 0.058 | CYP2D6 inhibitor | 0.026 |
CYP2D6 substrate | 0.174 | CYP2E1 substrate | 0.347 |
CYP3A4 inhibitor | 0.073 | CYP3A4 substrate | 0.102 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.779 | CL | 2.124 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.149 | Hepatotoxicity | 0.905 |
Mutagenicity | 0.016 | Rat Oral Acute Toxicity | 0.371 |
FDAMDD | 0.086 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.0 | Eye Corrosion | 0.002 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.046 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -1.834 | IGC50 | 2.681 |
LC50FM | 2.983 | LC50DM | 4.02 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.347 | NR-AR-LBD | 0.278 |
NR-AhR | 0.003 | NR-Aromatase | 0.026 |
NR-ER | 0.292 | NR-ER-LBD | 0.359 |
NR-PPAR-gamma | 0.51 | SR-ARE | 0.341 |
SR-ATAD5 | 0.355 | SR-HSE | 0.122 |
SR-MMP | 0.018 | SR-p53 | 0.046 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.